Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
US large, mid, and small-cap retirement index funds provide layered exposure to varying market segments. This intro covers allocation ideas and risk considerations.
26,127 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
When a major fund manager trims a stake in a top municipal income fund, it sparks questions about risk, yields, and s...
The VIX slid as optimism about geopolitical peace and cheaper oil spurred a broad market rally. Analysts caution the ...
A coordinated unwind of the Parabolic 7 sent Micron, Sandisk, and Marvell sliding Thursday morning, signaling a shift...
Bitcoin weakens as the dollar strengthens, signaling tighter liquidity and renewed selling pressure. Analysts warn th...
Equity futures fell and oil surged as the initial round of U.S.-Iran talks began, setting a tense tone for markets an...
Solana ETFs have drawn substantial institutional money despite a steep SOL price decline, signaling a shift in convic...
Warren Buffett is famous for value investing and extraordinary generosity. This article examines a potential new targ...
A disciplined look at AMEX shares through the lens of value, growth, and risk. Learn how to judge whether american ex...
Ethereum is the lone red stake among the top-10 cryptos this week, while Bitcoin and other large caps post gains as i...
A surge in AI infrastructure chips has lifted the Philadelphia Semiconductor Index, yet broad market participation is...
XCEM has risen 38% year-to-date, beating the S&P 500 by a wide margin as investors tilt toward emerging markets ex-Ch...